These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Drug selection in the treatment of Hodgkin's disease. Bonadonna G; Santoro A Hematol Oncol; 1983; 1(1):3-12. PubMed ID: 6203820 [No Abstract] [Full Text] [Related]
9. Lymphomatoid papulosis followed by Hodgkin's disease. Silva MM; Morais JC; Spector N; Maceira J; Sousa MA; Filgueira AL Int J Dermatol; 1998 Jul; 37(7):541-3. PubMed ID: 9679697 [No Abstract] [Full Text] [Related]
10. Pediatric Hodgkin's disease. Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795 [TBL] [Abstract][Full Text] [Related]
11. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease. Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754 [TBL] [Abstract][Full Text] [Related]
12. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma]. Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946 [TBL] [Abstract][Full Text] [Related]
13. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages? Andrieu JM; Colonna P J Clin Oncol; 1998 Jun; 16(6):2283. PubMed ID: 9626234 [No Abstract] [Full Text] [Related]
14. ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy. Clamon GH; Corder MP Cancer Treat Rep; 1978 Mar; 62(3):363-7. PubMed ID: 77188 [No Abstract] [Full Text] [Related]
15. Development of effective salvage treatment programs for Hodgkin's disease: an ongoing clinical challenge. Hoppe RT Blood; 1991 May; 77(10):2093-5. PubMed ID: 1709367 [No Abstract] [Full Text] [Related]
16. Cooperative trials of Hodgkin's lymphoma in the Federal Republic of Germany. Diehl V; Pfreundschuh M; Löffler M; Rühl U; Hiller E; Gerhartz H; Kirchner H J Cancer Res Clin Oncol; 1990; 116(1):106-8. PubMed ID: 1690208 [No Abstract] [Full Text] [Related]
17. Hodgkin's lymphoma--the great teacher. Connors JM N Engl J Med; 2011 Jul; 365(3):264-5. PubMed ID: 21774715 [No Abstract] [Full Text] [Related]
18. Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease. Bonadonna G; Zucali R; De Lena M; Valagussa P Cancer Treat Rep; 1977 Aug; 61(5):769-77. PubMed ID: 70270 [No Abstract] [Full Text] [Related]
19. Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987. Tubiana M; Henry-Amar M; Carde P; Burgers JM; Hayat M; Van der Schueren E; Noordijk EM; Tanguy A; Meerwaldt JH; Thomas J Blood; 1989 Jan; 73(1):47-56. PubMed ID: 2462943 [TBL] [Abstract][Full Text] [Related]
20. [Concomitant pulmonary Langerhans cell histiocytosis and malignant lymphoma: report of two cases]. Régis A; Ben Salem D; Lambert A; Couaillier JF; Casasnovas O; Piard F; Krausé D J Radiol; 2009 Jan; 90(1 Pt 1):66-8. PubMed ID: 19182717 [No Abstract] [Full Text] [Related] [Next] [New Search]